...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The Biotech Blindspot

Excellent article and makes me wonder where Don has been sleeping/snoozing at the switch.

Repare Therapeutics has develped a CRISPR based technology to create cancer treatment compounds and identify patients most likely to benefit called SNIPRx using synthetic lethality theory.

Repare has clinched a global deal with Bristol Myers Squibb and yet they have no drugs in clinical trials and are only at the IND stage.

Remarkable!!!

I'll post more about Repare hopefully tomorrow.

GLTA and "Happy Independence Day to our American" friends and partners.

Cheers

Toinv

 

Share
New Message
Please login to post a reply